Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid Crown Castle International Corp. (CCI)?

Page 1 of 2

Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players within the hedge fund industry can easily identify the undervalued and high-potential stocks that reside the ignored corners of equity markets. There are numerous small-cap stocks that have turned out to be great winners, which is one of the main reasons the Insider Monkey team pays close attention to the hedge fund activity in relation to these stocks.

Crown Castle International Corp. (NYSE:CCI) was in 46 hedge funds’ portfolios at the end of September. Crown Castle International Corp. (NYSE:CCI) investors should be aware of a decrease in enthusiasm from smart money of late. There were 48 hedge funds in our database with Crown Castle International Corp. (NYSE:CCI) holdings at the end of the previous quarter. At the end of this article, we will also compare Crown Castle International Corp. (NYSE:CCI) to other stocks, including Korea Electric Power Corporation (ADR) (NYSE:KEP), L Brands Inc (NYSE:LB), and BB&T Corporation (NYSE:BBT) to get a better sense of its popularity.

Follow Crown Castle International Corp (NYSE:CCI)
Trade (NYSE:CCI) Now!

According to most market participants, hedge funds are assumed to be unimportant, old investment vehicles of years past. While there are greater than 8000 funds with their doors open at the moment, our researchers look at the upper echelon of this group, around 700 funds. Most estimates calculate that this group of people controls the majority of the smart money’s total capital, and by keeping track of their unrivaled investments, Insider Monkey has discovered many investment strategies that have historically outpaced the broader indices. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points a year for a decade in their back tests.

With all of this in mind, we’re going to go over the latest action surrounding Crown Castle International Corp. (NYSE:CCI).

How have hedgies been trading Crown Castle International Corp. (NYSE:CCI)?

At the end of September, a total of 46 of the hedge funds tracked by Insider Monkey held long positions in this stock, a decline of 4% from the previous quarter. With hedgies’ sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Bill & Melinda Gates Foundation Trust, managed by Michael Larson, holds the most valuable position in Crown Castle International Corp. (NYSE:CCI). Bill & Melinda Gates Foundation Trust has a $420.6 million position in the stock, comprising 2.4% of its 13F portfolio. Sitting at the No. 2 spot is Andreas Halvorsen of Viking Global, with a $354.6 million position; the fund has 1.4% of its 13F portfolio invested in the stock. Other members of the smart money that hold long positions consist of Israel Englander’s Millennium Management, John Overdeck and David Siegel’s Two Sigma Advisors, and D E Shaw.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!